title: Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin.
authors.forename: A
authors.initials: A
authors.lastname: Heyll
authors.forename: C
authors.initials: C
authors.lastname: Aul
authors.forename: V
authors.initials: V
authors.lastname: Runde
authors.forename: M
authors.initials: M
authors.lastname: Arning
authors.forename: W
authors.initials: W
authors.lastname: Schneider
authors.forename: P
authors.initials: P
authors.lastname: Wernet
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D001787:Blood Group Incompatibility / Q000150:complications*; D016026:Bone Marrow Transplantation; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000017:ABO Blood-Group System; D011994:Recombinant Proteins; D004921:Erythropoietin